Hospitalization at Home: The Acute Care Home Hospital Program for Adults

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02864420
Collaborator
Partners HealthCare (Other), Smiths Medical, ASD, Inc. (Industry), Vital Connect, Inc. (Other)
21
2
2
3
10.5
3.5

Study Details

Study Description

Brief Summary

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.

Condition or Disease Intervention/Treatment Phase
  • Other: Home hospitalization
  • Other: Inpatient Hospitalization
N/A

Detailed Description

Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is poor: many hospital wards are typically over 100% capacity, and emergency department waits can be protracted. Moreover, hospital care is increasingly costly: many internal medicine admissions have a negative margin (i.e., expenditures exceed hospital revenues) and incur patient debt.

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, 20% reduced cost, and 20% improved patient experience. While this is the standard of care in several developed countries, only 2 non-randomized demonstration projects have been conducted in the United States, each with highly local needs. Taken together, home hospital evidence is promising but falls short due to non-robust experimental design, failure to implement modern medical technology, and poor enlistment of community support.

The home hospital module offers most of the same medical components that are standard of care in an acute care hospital. The typical staff (medical doctor [MD], registered nurse [RN], case manager), diagnostics (blood tests, vital signs, telemetry, x-ray, and ultrasound), intravenous therapy, and oxygen/nebulizer therapy will all be available for home hospital. Optional deployment of food services, home health aide, physical therapist, occupational therapist, and social worker will be tailored to patient need. Home hospital improves upon the components of a typical ward's standard of care in several ways:

  • Point of care blood diagnostics (results at the bedside in <5 minutes);

  • Minimally invasive continuous vital signs, telemetry, activity tracking, and sleep tracking;

  • On-demand 24/7 clinician video visits;

  • 4 to 1 patient to MD ratio, compared to typical 16 to 1;

  • Ambulatory/portable infusion pumps that can be worn on the hip;

  • Optional access to a personal home health aide

Should a matter be emergent (that is, requiring in-person assistance in less than 20 minutes), then 9-1-1 will be called and the patient will be returned to the hospital immediately. In previous iterations of home hospital this happens in about 2% of patients.

Clinical parameters measured will be at the discretion of the physician and nurse, who treat the participant following evidence-based practice guidelines, just as in the usual care setting. In addition, the investigators will be tracking a wide variety of measures of quality and safety, including some measures tailored to each primary diagnosis.

Study Design

Study Type:
Interventional
Actual Enrollment :
21 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Hospitalization at Home Pilot: The Acute Care Home Hospital Program for Adults
Actual Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Inpatient hospitalization

Control / usual care arm. Patients are admitted per usual to an inpatient service. Patients' medical records will be closely monitored. Patients will wear a vitals and activity monitor whose data is used only retrospectively. On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.

Other: Inpatient Hospitalization

Experimental: Home hospitalization

Intervention arm. Patients will return home after triage, diagnosis, and the beginning of treatment in the emergency department with a set of specialized patient-tailored services (listed above). On discharge and 30 days after discharge, they will be interviewed regarding their hospitalization and health.

Other: Home hospitalization

Outcome Measures

Primary Outcome Measures

  1. Total cost of hospitalization, $ [Day of admission to day of discharge]

Secondary Outcome Measures

  1. Direct margin, $ [Day of admission to day of discharge]

    Direct margin from total cost of hospitalization

  2. Direct margin, modeled with backfill, $ [Day of admission to day of discharge]

    Backfill uses a model that estimates the cost of patients who take the place of home hospital patients

  3. Length of stay, days [Day of admission to day of discharge]

  4. Imaging, # [Day of admission to day of discharge]

  5. Lab Orders, # [Day of admission to day of discharge]

  6. Discharge Disposition [Day of discharge]

    Routine, skilled nursing facility, home health, other

  7. Readmission(s) after index hospitalization, y/n [Day of discharge to 30 days later]

    Dichotomous outcome

  8. Time to readmission after index hospitalization, days [Day of discharge to 30 days later]

    Survival curve (hazard analysis)

  9. Emergency Department (ED) observation stay(s) after index hospitalization, y/n [Day of discharge to 30 days later]

    Dichotomous outcome

  10. Time to ED observation stay(s) after index hospitalization, days [Day of discharge to 30 days later]

    Survival curve (hazard analysis)

  11. ED visit(s) after index hospitalization, y/n [Day of discharge to 30 days later]

    Dichotomous outcome

  12. Time to ED visit(s) after index hospitalization, days [Day of discharge to 30 days later]

    Survival curve (hazard analysis)

  13. Delirium, y/n [Day of admission to day of discharge]

  14. Transfer back to hospital, y/n [Day of admission to day of discharge]

    intervention arm only

  15. Hours of sleep, # [Day of admission to day of discharge]

  16. Daily steps, # [Day of admission to day of discharge]

  17. EuroQol -5D-5L, composite score [At admission, at discharge, and at 30 days after discharge]

  18. Short Form 1 [30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge]

    1-5 Likert scale

  19. Activities of daily living, score [30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge]

  20. Instrumental activities of daily living, score [30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge]

  21. 3-item Care Transition Measure, score [30 days after discharge]

  22. Picker Experience Questionnaire, score [30 days after discharge]

  23. Global satisfaction with care, score [30 days after discharge]

  24. Qualitative interview [30 days after discharge]

Other Outcome Measures

  1. Total cost of episode of care, $ [Day of admission to 30 days after discharge]

    Exploratory; Subset of sample for which claims data is available

  2. Intraveneous medications, days [Day of admission to day of discharge]

    Exploratory

  3. Intraveneous fluids, days [Day of admission to day of discharge]

    Exploratory

  4. Intraveneous diuretics, days [Day of admission to day of discharge]

    Exploratory

  5. Intraveneous antibiotics, days [Day of admission to day of discharge]

    Exploratory

  6. Supplemental oxygen required, days [Day of admission to day of discharge]

    Exploratory

  7. Nebulizer treatment, days [Day of admission to day of discharge]

    Exploratory

  8. Medical Doctor sessions, # notes [Day of admission to day of discharge]

    Exploratory

  9. Consultant sessions, # notes [Day of admission to day of discharge]

    Exploratory

  10. Physical therapy/occupational therapy sessions, # notes [Day of admission to day of discharge]

    Exploratory

  11. Primary care provider follow-up within 14 days, y/n [Day of discharge to 14 days later]

    Exploratory

  12. Skilled nursing facility utilization, days [Day of discharge to 30 days later]

    Exploratory

  13. Home health utilization, days [Day of discharge to 30 days later]

    Exploratory

  14. Fall, y/n [Day of admission to day of discharge]

    Exploratory

  15. Diagnosis of hospital-acquired or post-discharge deep vein thrombosis or pulmonary embolism [Day of admission to 30 days after discharge]

    Exploratory

  16. Hospital-acquired pressure ulcer, y/n [Day of admission to day of discharge]

    Exploratory

  17. Thrombophlebitis at peripheral intravenous site, y/n [Day of admission to day of discharge]

    Exploratory

  18. Catheter-associated urinary tract infection, y/n [Day of admission to day of discharge]

    Exploratory

  19. Clostridium difficile infection, y/n [Day of admission to day of discharge]

    Exploratory

  20. Methicillin resistant staph aureus infection, y/n [Day of admission to day of discharge]

    Exploratory

  21. Mortality during admission, y/n [Day of admission to day of discharge]

    Exploratory

  22. Post-discharge mortality, y/n [Day of discharge to 30 days later]

    Exploratory

  23. New arrhythmia, y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  24. Hypokalemia, y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  25. Acute kidney injury, y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  26. Mean Likert scale pain score, 0-10 [Day of admission to day of discharge]

    Exploratory

  27. Pneumococcal vaccination if appropriate, y/n [Day of admission to day of discharge]

    Pneumonia patients only; Exploratory

  28. Influenza vaccination if appropriate, y/n [Day of admission to day of discharge]

    Pneumonia patients only; Exploratory

  29. Smoking cessation counseling if appropriate, y/n [Day of admission to day of discharge]

    Pneumonia and heart failure patients only; Exploratory

  30. Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography

  31. Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  32. Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  33. Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  34. Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n [Day of admission to day of discharge]

    Heart failure patients only; Exploratory

  35. Smoking status post-discharge [30 days after day of discharge]

    Heart failure and pneumonia patients only; Exploratory; current/never/quit.

  36. Use of inappropriate medications in the elderly, y/n [Day of admission to day of discharge]

    Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria

  37. Use of Foley catheter, y/n [Day of admission to day of discharge]

    Exploratory

  38. Use of restraints, y/n [Day of admission to day of discharge]

    Exploratory

  39. >3 medications added to medication list, y/n [Day of discharge (compared with preadmission med list)]

    Exploratory

  40. Patient health questionnaire-2, score [30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge]

    Exploratory

  41. Patient-Reported Outcomes Measurement Information System Emotional Support Short Form 4a, score [30 days prior to admission (asked on day of admission), at admission, at discharge, and at 30 days after discharge]

    Exploratory

  42. Walk around ward/home, y/n [Day of discharge]

    Exploratory

  43. Get to (non-commode) bathroom, y/n [Day of discharge]

    Exploratory

  44. Walk 1 flight of stairs, y/n [Day of discharge]

    Exploratory

  45. Visit with friends/family, y/n [Day of admission to day of discharge]

    Exploratory

  46. Walk outside around my home, y/n [30 days after discharge]

    Exploratory

  47. Go shopping, y/n [30 days after discharge]

    Exploratory

  48. Time from admission decision to assessment by research assistant, minutes [Day of admission]

    Exploratory

  49. Time from research assistant assessment to emergency department dismissal, minutes [Day of admission]

    Exploratory

  50. Time from arrival home or to floor and medical doctor evaluation, minutes [Day of admission]

    Exploratory

  51. Time from arrival home or to floor and registered nurse evaluation, minutes [Day of admission]

    Exploratory

  52. Average Registered nurse to patient ratio [Day of admission to day of discharge]

    Exploratory

  53. Number of registered nurse visits, total [Day of admission to day of discharge]

    Exploratory

  54. Number of "on call" medical doctor interactions (video or phone), total [Day of admission to day of discharge]

    Exploratory, intervention arm only

  55. Number of "on call" medical doctor in-person visits, total [Day of admission to day of discharge]

    Exploratory, intervention arm only

  56. Duration of 1st registered nurse visit, minutes [Day of admission]

    Exploratory, intervention arm only

  57. Average Duration of subsequent registered nurse visit, minutes [Day of admission to day of discharge]

    Exploratory, intervention arm only

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Resides within 5-mile radius of emergency room

  • English- or Spanish-speaker

  • Can identify a potential caregiver who agrees to stay with patient for first 24 hours of admission. Caregiver must be competent to call care team if a problem is evident to her/him.

  • This criterion may be waived for highly competent patients at the patient and clinician's discretion.

  • =18 years old

  • Primary diagnosis of cellulitis, heart failure, complicated urinary tract infection, or pneumonia that requires inpatient admission as determined by blinded emergency room team.

Exclusion Criteria:
  • Undomiciled

  • No working heat (October-April), no working air conditioning if forecast > 80°F (June-September), or no running water

  • On methadone requiring daily pickup of medication

  • In police custody

  • Resides in facility that provides on-site medical care (e.g., skilled nursing facility)

  • Domestic violence screen positive

  • Cared for by a private primary care physician who rounds in the hospital

  • Cannot establish peripheral access in emergency department (or access requires ultrasound guidance)

  • Secondary condition: active non-melanoma/prostate cancer, end-stage renal disease, acute myocardial infarction, acute cerebral vascular accident, acute hemorrhage

  • Primary diagnosis requires narcotics for pain control

  • Cannot independently ambulate to bedside commode

  • As deemed by on-call medical doctor, patient likely to require any of the following procedures: computed tomography, magnetic resonance imaging, endoscopic procedure, blood transfusion, cardiac stress test, or surgery

  • For pneumonia:

  • Most recent CURB65 > 3: new confusion, blood urea nitrogen > 19mg/dL, respiratory rate>=30/min, systolic blood pressure<90mmHg, Age>=65

  • Most recent SMRTCO > 2: systolic blood pressure < 90mmHg (2pts), multilobar chest xray involvement (1pt), respiratory rate >= 30/min, heart rate >= 125, new confusion, oxygen saturation <= 90%

  • Absence of clear infiltrate on imaging

  • Cavitary lesion on imaging

  • O2 saturation < 90% despite 5L O2

  • For heart failure:

  • Has a left ventricular assist device or paced rhythm

  • Get with the Guidelines - Heart Failure (>10% in-hospital mortality) or The Acute Decompensated Heart Failure National Registry score (high risk or intermediate risk 1)

  • Anasarca

  • Pulmonary hypertension

  • For complicated urinary tract infection:

  • Absence of pyuria

  • Most recent quick sepsis related organ failure assessment > 1

  • Home hospital census is full (maximum 4 patients at any time)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Hospital Boston Massachusetts United States 02120
2 Brigham and Women's Faulkner Hospital Boston Massachusetts United States 02130

Sponsors and Collaborators

  • Brigham and Women's Hospital
  • Partners HealthCare
  • Smiths Medical, ASD, Inc.
  • Vital Connect, Inc.

Investigators

  • Principal Investigator: Jeffrey L Schnipper, MD, MPH, Brigham and Women's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeffrey L. Schnipper, MD.,MPH., Associate Physician, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT02864420
Other Study ID Numbers:
  • 2016P001337
First Posted:
Aug 12, 2016
Last Update Posted:
Jul 11, 2017
Last Verified:
Jul 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Jeffrey L. Schnipper, MD.,MPH., Associate Physician, Brigham and Women's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2017